SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S. Corbett, Hamilton Bennett, Barney S. Graham et al.|Nature|2020Cited by 1.7k
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primatesBryan E. Jones, Nicole V. Johnson, Patricia Brown‐Augsburger et al.|Science Translational Medicine|2021Cited by 503
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S. Corbett, Tracy J. Ruckwardt, Darin K. Edwards et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 143
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, John R. Mascola, Daniel Wrapp et al.|Immunity|2021Cited by 71
Human Coronavirus HKU1 Neutralizing Monoclonal Antibodies Target Diverse Epitopes Within and Around the TMPRSS2 Receptor Binding SiteLingshu Wang, Kizzmekia S. Corbett, Jeswin Joseph et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1